Researchers at the University of Bath in the UK have developed a wearable belt-like device that can continuously scan the ...

Scientists from Kaunas University of Technology (KTU), Lithuania, have developed a system for integrated post-stroke ...

British healthtech company Huma Therapeutics has partnered with Eckuity Capital to lay the foundations for an ‘aggressive’ ...

Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants. Yet distinguishing its true clinical promise from the financial buzz is no easy task.

Implantable lens developer STAAR will fund the repurchase using cash on hand and money generated from business operations.

GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.

Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT (optical coherence tomography) platform ...

The Final Rule was mooted for implementation over a staged transition period, determined by a service’s risk level, by 2028.

The FDA has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System.

New research has revealed that UK adults feel "let down" by mental health services provided by the UK's National Health ...

The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.

Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...